As per this study the Global Oxycodone Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2027 with a CAGR of XX%.
Oxycodone is a narcotic drug used to provide relief from moderate to severe pain. It is a prescribed medicine that slows downs the signal traveling from the brain to the body. Oxycodone is available in various forms such as immediate release tablet & capsule, extended release tablet & capsule form that can be consumed orally.
Growing commonness of cancer, Parkinson’s disease, rheumatic diseases is driving the market growth. Use of oxycodone to impart relief from postoperative pain under various medical conditions is again fueling the market growth. However, growing concern related to opioid abuse is restraining the market growth. Nevertheless, FDA approved less addictive oxycodone drugs for adults and children are likely to open new gateways for the market growth in the forecasting period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of oxycodone.
The broad oxycodone market has been sub-grouped into product type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product Type
- Long Acting Oxycodone
- Short Acting Oxycodone
- Hospital Pharmacies
- Retail Pharmacies
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for oxycodone in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Oxycodone Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the oxycodone market include Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals, Mallinckrodt, Mylan, Sun Pharmaceutical, Impax Laboratories and Indivior. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.